Low tetanus, diphtheria and acellular pertussis (Tdap) vaccination coverage among HIV infected individuals in Austria

Vaccine

Volumn 33, Issue 32, 2015, Pages 3929-3932

  Grabmeier Pfistershammer, K ^a   Herkner, H ^b   Touzeau Roemer, V ^a   Rieger, A ^a   Burgmann, H ^b   Poeppl, W ^a,b  

^a Universitatsklinik fur Dermatologie   (Austria)

^b MEDICAL UNIVERSITY OF VIENNA   (Austria)

Author keywords

Diphtheria, Vaccination; HIV; Immunodeficiency; Migration; Prevention

Indexed keywords

ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT; DIPHTHERIA PERTUSSIS TETANUS VACCINE; ANTIRETROVIRUS AGENT; ANTITOXIN; BACTERIUM ANTIBODY; VIRUS ANTIBODY;

ADULT; ARTICLE; AUSTRIA; AUSTRIAN; CD4 LYMPHOCYTE COUNT; CROSS-SECTIONAL STUDY; DIPHTHERIA; DISEASE COURSE; DISEASE TRANSMISSION; FEMALE; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE STATUS; MAJOR CLINICAL STUDY; MALE; MIGRANT; PERTUSSIS; PRIORITY JOURNAL; TETANUS; TETANUS PROPHYLAXIS; VACCINATION; BLOOD; COMPLICATION; DRUG UTILIZATION; EPIDEMIOLOGY; HIV INFECTIONS; IMMUNOLOGY; MIDDLE AGED; WHOOPING COUGH;

ADULT; ANTI-RETROVIRAL AGENTS; ANTIBODIES, BACTERIAL; ANTIBODIES, VIRAL; ANTITOXINS; AUSTRIA; CD4 LYMPHOCYTE COUNT; CROSS-SECTIONAL STUDIES; DIPHTHERIA; DIPHTHERIA-TETANUS-ACELLULAR PERTUSSIS VACCINES; DRUG UTILIZATION; FEMALE; HIV INFECTIONS; HUMANS; MALE; MIDDLE AGED; SEROEPIDEMIOLOGIC STUDIES; TETANUS; WHOOPING COUGH;

EID: 84937516013     PISSN: 0264410X     EISSN: 18732518     Source Type: Journal    
DOI: 10.1016/j.vaccine.2015.06.056     Document Type: Article

References (26)

1. Janoff E.N., Breiman R.F., Daley C.L., Hopewell P.C. Pneumococcal disease during HIV infection. Epidemiologic, clinical, and immunologic perspectives. Ann Intern Med 1992, 117(Aug (4)):314-324.
2. Wateba M., Diop S., Nichols S., et al. Tetanus and HIV: a fortuitous association. Sante 2008, 18(Jul-Sep (3)):131-134.
3. Belaunzarán-Zamudio PF1, García-León M.L., Wong-Chew R.M., Villasís-Keever A., Cuellar-Rodríguez J., Mosqueda-Gómez J.L., et al. Early loss of measles antibodies after MMR vaccine among HIV-infected adults receiving HAART. Vaccine 2009, 27(Nov (50)):7059-7064.
4. Aurpibul L., Puthanakit T., Sirisanthana T., Sirisanthana V. Response to measles, mumps, and rubella revaccination in HIV-infected children with immune recovery after highly active antiretroviral therapy. Clin Infect Dis 2007, 45(Sep (5)):637-642.
5. Berkelhamer S., Borock E., Elsen C., Englund J., Johnson D. Effect of highly active antiretroviral therapy on the serological response to additional measles vaccinations in human immunodeficiency virus-infected children. Clin Infect Dis 2001, 32(Apr (7)):1090-1094.
6. Geretti A.M., Brook G., Cameron C., Chadwick D., Heyderman R.S. British HIV Association guidelines for immunization of HIV-infected adults 2008. HIV Med 2008, 9(Nov (10)):795-848. BHIVA Immunization Writing Committee.
7. Centers for Disease Control and Prevention (CDC) Updated recommendations for use of tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis vaccine (Tdap) in pregnant women - Advisory Committee on Immunization Practices (ACIP), 2012. MMWR 2013, 62(Feb (22)):131-135.
8. EACS Guidelines vers 7.1, 11/2014, 2014; . http://www.eacsociety.org/files/guidelines-7.1-english.pdf.
9. CDC Tetanus and pertussis vaccination coverage among adults aged ≥18 Years-United States, 1999 and 2008. MMWR 2010, 59(Aug (32)):1302-1306.
10. CDC National, state, and local area vaccination coverage among adolescents aged 13-17 years-United States 2009. MMWR 2010, 59(Aug (32)):1018-1023.
11. Tanriover M.D., Soyler C., Ascioglu S., Cankurtaran M., Unal S. Low seroprevalence of diphtheria, tetanus and pertussis in ambulatory adult patients: the need for lifelong vaccination. Eur J Intern Med 2014, 25(Jul (6)):528-532.
12. CDC Final 2009 reports of nationally notifiable diseases. MMWR 2010, 59(Aug (32)). (1025-1027-1039).
13. CDC Updated recommendations for use of tetanus toxoid, reduced diphtheria toxoid and acellular pertussis (Tdap) Vaccine from the Advisory Committee on Immunization Practices, 2010. MMWR 2011, 60(Jan (14)):13-15.
14. Grabmeier-Pfistershammer K., Poeppl W., Herkner H., Touzeau-Roemer V., Huschka E., Rieger A., et al. High need for MMR vaccination in HIV infected adults in Austria. Vaccine 2014, 32(Oct (45)):6020-6023.
15. Impfplan Österreich 2015, 〈〉. http://bmg.gv.at/cms/home/attachments/8/9/4/CH1100/CMS1389365860013/impfplan.pdf.
16. Rohani P., Drake J.M. The decline and resurgence of pertussis in the US. Epidemics 2011, 3(Sep (3-4)):183-188. 10.1016/j.epidem.2011.10.001.
17. Celentano L.P., Massari M., Paramatti D., Salmaso S. Resurgence of pertussis in Europe. Pediatr Infect Dis J 2005, 24(9):761-765. Tozzi AE EUVAC-NET Group.
18. Alagappan K., Mc Gowan J., DeClaro D., et al. Tetanus antibody protection among HIV-infected US-born patients and immigrants. Int J Emerg Med 2008, 1(Jun (2)):123-126.
19. Alagappan K., Rennie W., Kwaitkowski T., et al. Seroprevalence of tetanus antibodies among adults older than 65 years. Ann Emerg Med 1996, 28(Jul (1)):18-21.
20. Weiss B.P., Strassburg M.A., Feeley J.C. Tetanus and diphtheria immunity in an elderly population in Los Angeles County. Am J Public Health 1983, 73(7):802-804.
21. Waldorf B., Gill C., Crosby S.S. Assessing adherence to accepted national guidelines for immigrant and refugee screening and vaccines in an urban primary care practice: a retrospective chart review. J Immigr Minor Health 2014, 16(Oct (5)):839-845.
22. Galazka A.M., Robertson S.E., Oblapenko G.P. Resurgence of diphtheria. Eur J Epidemiol 1995, 11(Feb (1)):95-105.
23. Marlovits S., Stocker R., Efstratiou A. Seroprevalence of diphtheria immunity among injured adults in Austria. Vaccine 2000, 19(Dec (9-10)):1061-1067.
24. Sutcliff C.G., Moss W.J. Do children with HIV receiving HAART need to be revaccinated?. Lancet Inf Dis 2010, 10(9):630-642.
25. Kemper C.A., Zolopa A.R., Hamilton J.R., Fenstersheib M., Bhatia G., Deresinski S.C. Prevalence of measles antibodies in adults with HIV infection: possible risk factors of measles seronegativity. AIDS 1992, 6(11):1321-1325.
26. Austrian HIV Cohort Study 26th Report of the Austrian HIV Cohort Study (2014) Edited by Robert Zangerle 2014, STUDIA Universitätsverlag, Innsbruck, Austria, 〈dermatologie.uki.at/data.cfm?vpath=dokumente/kohortenbericht〉.